Sunil D

In-depth primary and secondary research in the pharmaceutical sector, focusing on the US market. This includes analysis of market trends, key competitors, competitive landscape, treatment paradigms, unmet needs, company profiles, product pipelines, clinical trials, regulatory bodies, and company profiling

Therapeutic area expertise in BoNT (Botulinum toxin), Parkinson Disease (OFF episodes) and Multiple Sclerosis (Walking Disability) and Inherited Retinal Diseases

Lead and take accountability for all assigned ongoing projects (existing and new) for one or more accounts in the pharmaceutical and healthcare domain, and possibly other sectors

Conduct, and propel team to conduct primary research with KOLs across different functions and levels through different modes of communication (scheduled and cold-calls, LinkedIn, email, Google Surveys, etc.), and support team by framing appropriate scripts and questionnaires

On-board new FTE clients, set up processes and protocols - maintain extra layer of supervision and involvement during initial 6 months to ensure client delight

Support business development activities through developing strong relationships with existing clients to generate up-sell and cross-sell opportunities

•Led competitive intelligence programsfor athenahealth (GE Healthcare) US healthcare division

•Collaboration with marketing,sales, and product developmentteams to align insights with business goals

•Monitoredcompetitorsand provided reports on industrytrends and emergingdevelopments

•Create and deliver detailed reports, including SWOT analyses, win/loss analysis, competitor benchmarking, and market trend assessments, to inform strategic planningand productdevelopment

•Managed vendor relationships and ensured compliance with all competitive intelligence processes

•Created executive-level presentations to convey actionable insights, facilitating informed decision-making across departments

•Generate actionable insights by conducting surveys, interviews, focus groups, and market research to understand market dynamics, identify trends, and assess competitive landscapes

•Competitive Intelligence for SCD/ Thalassemia, Pain Management and Inherited retinal diseases indications. Continuous monitoring, tracking, and preparing insight generations in the form of newsletters, alerts, and monthly/quarterly reports.

•Delivered high-quality CI projects that included real-time CI alerts, detailed landscape decks, comprehensive conference coverage, and in-depth competitor benchmarking

•Conducted in-depth qualitative research (e.g., in-depth interviews, focus groups) to understand patient journeys, unmet needs, and emotional responses to therapies.

•Developed and implemented robust primary research methodologies (e.g., surveys, interviews, focus groups) to collect high-quality data from target audiences (patients, healthcare professionals, payers)

Detailed analysis of marketed & pipeline products, treatment guidelines, unmet needs, and market trends

•Created market intelligence briefings using real-time alerts and written key insights about their impact on the current landscape for Infectiousdiseases (HIV, HBV, HCV), Metabolic (CKD-MBD, DKD) area.

•Prepared competitive disease landscapes including product profiles, news & deals, clinical trial details, launch estimates, and life cycle management

•Conducted epidemiology analysis to estimate market size for product targeting specific populations

•Led and executed primary research studies to collect high-quality data from key stakeholders.

•Conducted robust primary research to understand market dynamics and inform strategic decisions.

•Involvedin end-to-end conference support including pre-conference, on-site, and post-conference

•Providing key insights to clientson strategies to be adopted for brand or disease-specific campaigns and help them engage effectively with HCPs and patient communities

•Created competitive digital intelligence landscapes covering a wide range of analyses for websites, mobile apps, and social media accounts

•Identificationof sources of information (Primary andSecondary sources)

•Research analysis for various Pharmaceutical Companies based on their annual reports, compliance

reportsand other secondary sources

•Conducted market researchto identify emerging trends, uncover untapped opportunities, assess potential threats, and gain a deep understandingof customer needs and preferences

•Develop analytical structure by aligningthe information generated through primary sources like in- depth interviews of respondents and secondary sources

Developed and refined research instruments (questionnaires, discussion guides) for diverse stakeholder interviews, including physicians, and patients